Sign In
Buy ISSC
$18.29
+0.83 (+4.75%)
At Close: Jul 31, 2026
Innovative Solutions and Support Reports Q3 Loss of $0.21/Share vs Loss of $0.02/Share Est., Sales $4.9M vs $12.5M Est.
12:00am, Wednesday, 05'th Aug 2015Innovative Solutions and Support's (ISSC) CEO Geoff Hedrick on Q2 2015 Results - Earnings Call Transcript
12:00am, Thursday, 07'th May 2015Innovative Solutions and Support misses by $0.05, misses on revenue
12:00am, Wednesday, 06'th May 2015Innovative Solutions May Not Fully Recover From Delta's Cancellation
12:00am, Friday, 23'rd Jan 2015Innovative Solutions and Support's (ISSC) CEO Geoff Hedrick on Q1 2015 Results - Earnings Call Transcript
12:00am, Thursday, 22'nd Jan 2015Innovative Solutions Reports Q1 EPS of $0.03; Revenue of $6.724M
12:00am, Wednesday, 21'st Jan 2015Innovative Solutions and SUpport, Inc. Reports Q4 EPS of $(0.12) vs $0.04 Est; Revenue of $9.90M vs $10.58M Est
12:00am, Wednesday, 03'rd Dec 2014Innovative Solutions & Support Board Authorizes Stock Repurchase Program of Up to 250K Shares
12:00am, Tuesday, 22'nd Apr 2014Innovative Solutions and SUpport, Inc. Reports Q3 EPS of $0.01 vs $0.03 Est; Revenue of $8.04M vs $9.70M Est
12:00am, Wednesday, 04'th Dec 2013Nanotherapeutics – Nanotechnology and Homeland Defense
06:59am, Thursday, 07'th Nov 2013
In previous articles, we have discussed the potential of nanotechnology-enabled drug delivery systems such as those offered by Nanoviricides and Bind Therapeutics. One private company funded by the Un
